What is the role of medical affairs in internal communications?

Anthony Stackman · 20 Oct 2026

Medical affairs plays a central role in internal communications by translating complex clinical and scientific information into clear, credible messaging that the wider organisation can understand and act on. In pharmaceutical and healthcare companies, medical affairs teams sit at the intersection of science, strategy, and stakeholder engagement — which puts them in a strong position to shape how information flows internally. The questions below explore how that role works in practice, from day-to-day content production to crisis response and organisational structure.

How does medical affairs bridge science and internal stakeholders?

Medical affairs acts as the organisation’s scientific conscience, ensuring that clinical evidence, regulatory context, and medical strategy are accurately represented in communications directed at non-specialist colleagues. Rather than simply passing information along, medical affairs interprets it, contextualises it, and frames it in ways that are relevant to each internal audience.

This matters because the gap between scientific data and commercial or operational decision-making is significant. A clinical trial result means something very different to a medical science liaison than it does to a brand manager or a supply chain lead. Medical affairs translates across those differences, helping internal stakeholders engage with evidence without misrepresenting it or oversimplifying it to the point of inaccuracy.

In practice, this means medical affairs professionals are frequently involved in briefing commercial teams before product launches, advising HR or training functions on disease education, and supporting leadership communications on therapeutic strategy. Their role is not just informational but interpretive — and that distinction is what gives internal communications from medical affairs its credibility.

What types of internal communications does medical affairs produce?

Medical affairs teams produce a wide range of internal communications: medical information summaries, scientific platform documents, field force training materials, internal newsletters or bulletins on pipeline developments, and briefing documents for senior leadership. Each format serves a different audience and a different stage of the information journey.

Scientific platform documents and evidence summaries are typically produced for internal alignment ahead of launches or label updates, ensuring that commercial, regulatory, and market access colleagues are working from the same evidential foundation. Medical affairs also produces reactive content — responses to unsolicited internal queries about off-label use, safety signals, or competitor data.

Increasingly, medical affairs teams are contributing to digital internal communications, including intranet content, e-learning modules, and video briefings. These formats allow scientific content to reach dispersed field teams and international affiliates consistently and in a governed way, reducing the message drift that can occur when scientific information passes through multiple layers of informal communication.

How does medical affairs support internal training and education?

Medical affairs supports internal training and education by developing and validating the scientific content that underpins learning programmes for commercial teams, medical science liaisons, and other functions. This includes disease area education, product training, clinical data interpretation, and guidance on compliant communication with healthcare professionals.

The medical affairs contribution to training is not just about accuracy, though that is essential. It is also about ensuring that internal teams understand the boundaries of what can and cannot be communicated externally — particularly in highly regulated environments where promotional and non-promotional content must remain clearly distinct. Medical affairs teams often work closely with regulatory, legal, and compliance functions to build those guardrails into training design from the outset.

Digital learning has become a significant delivery channel for this kind of education, allowing medical affairs to reach field teams across multiple markets with consistent, version-controlled content. Interactive modules, scenario-based learning, and virtual congress summaries are all formats that medical affairs teams are increasingly involved in producing or co-developing with learning and development functions.

What is the relationship between medical affairs and the commercial team?

The relationship is one of strategic interdependence. Medical affairs provides the scientific credibility and evidence framework that commercial activity depends on; the commercial team provides market insight that helps medical affairs prioritise its communications and engagement activities.

In practice, this relationship can be a source of productive tension. Commercial teams are focused on growth objectives, while medical affairs is responsible for maintaining scientific integrity across all communications. When that tension is well managed, it produces internal communications that are both compelling and accurate. When it is poorly managed, it can lead to oversimplification, compliance risk, or a breakdown in trust between functions.

Strong internal communications between medical affairs and commercial teams tend to be structured around shared planning cycles, joint briefings ahead of congresses or data readouts, and clearly defined escalation pathways when scientific and commercial perspectives diverge. Medical affairs should not be positioned as a gatekeeper that slows commercial momentum, but as a strategic partner that protects the organisation’s credibility while helping the commercial team tell a coherent, evidence-based story.

How does medical affairs contribute to internal crisis and issue communications?

Medical affairs contributes by providing rapid, accurate scientific assessment of emerging safety signals, competitor data, regulatory decisions, or clinical trial outcomes that require an organisational response. In a crisis, the speed and clarity of that scientific input can determine how effectively the organisation responds — both internally and externally.

When a safety signal emerges, medical affairs is typically the first function to assess the clinical significance of the data and advise leadership on what it means for patients, prescribers, and the organisation’s position. That assessment then shapes the internal briefing that goes to commercial teams, field forces, and senior leadership, ensuring that everyone is working from the same factual baseline before any external communication is made.

Medical affairs also plays a role in issue anticipation — identifying scientific developments in the competitive landscape or regulatory environment that could become internal communications challenges. Proactive briefings on upcoming data releases, label changes, or guideline updates help internal stakeholders prepare rather than react, which is a hallmark of a mature medical affairs function.

How should companies structure medical affairs for stronger internal communications?

Give medical affairs clear ownership of scientific content governance, defined cross-functional relationships with commercial, regulatory, and HR teams, and the operational resources to produce communications at pace and at scale. Structure follows strategy — if internal communications is a stated priority, it needs to be reflected in how the function is resourced and connected.

Several structural decisions have a direct impact on internal communications effectiveness:

Embedded vs. centralised models: Embedding medical affairs professionals within therapeutic area teams improves responsiveness and relationship quality with commercial colleagues, while centralised models offer greater consistency and governance. Hybrid structures are increasingly common.
Cross-functional governance: Regular forums that bring medical affairs together with commercial, regulatory, and market access functions create the conditions for aligned internal messaging rather than siloed content production.
Content ownership and version control: Assigning clear ownership of internal scientific content, with defined review and approval workflows, prevents outdated or inconsistent information from circulating across the organisation.
Channel strategy: Medical affairs should have a view on which internal channels are appropriate for different types of scientific content, from secure intranet platforms for sensitive data to field force briefing tools for time-sensitive updates.

The most effective medical affairs functions treat internal communications as a discipline in its own right — not a by-product of external activity. That means investing in the craft of scientific storytelling as well as the rigour of scientific review.

How we help with medical affairs internal communications

We work with pharmaceutical and healthcare organisations on the quality, clarity, and impact of their medical affairs communications — internal and external. With more than two decades of medcomms experience, we bring together scientific understanding and creative expertise to help medical affairs teams communicate more effectively across the organisation.

Development of internal scientific platforms, briefing documents, and evidence summaries
Digital learning content and e-modules for field force and commercial team education
Internal communications strategy and planning for medical affairs functions
Film, animation, and interactive content to bring complex science to life for non-specialist internal audiences
Cross-functional communications frameworks that align medical affairs, commercial, and regulatory messaging

If your medical affairs function is looking to raise the standard of its internal communications, get in touch with the Wizzard team to explore how we can help.